logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

BEKE-W (02423) repurchased approximately 239,600 shares for about US$1.5 million on November 5.

date
18:35 06/11/2026
avatar
GMT Eight
BEKE-W (02423) announced that on November 5, 2026, it repurchased approximately 239,600 shares for approximately US$1.5 million.
BEKE-W (02423) announced that on November 5, 2026, it repurchased approximately 239,600 shares for approximately US$1.5 million.
Related Articles
HK Stock
CHINA EAST AIR (00670) repurchased 5.1023 million A shares on November 6 for approximately RMB18.0002 million.
HK Stock
Lingyi Itech (01688) repurchased 2.0704 million shares on November 6 for HK$11.463 million.
China Stock
Zhejiang Yatai Pharmaceutical (002370.SZ)'s actual controller proposes a share repurchase of RMB10 million to RMB20 million.
CHINA EAST AIR (00670) repurchased 5.1023 million A shares on November 6 for approximately RMB18.0002 million.
HK Stock
Lingyi Itech (01688) repurchased 2.0704 million shares on November 6 for HK$11.463 million.
HK Stock
Zhejiang Yatai Pharmaceutical (002370.SZ)'s actual controller proposes a share repurchase of RMB10 million to RMB20 million.
China Stock
RECOMMEND
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
icon
25/09/2026
From IT Services to Enterprise AI: What ATGL Must Prove Next
From IT Services to Enterprise AI: What ATGL Must Prove Next
icon
24/09/2026
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.